T1	Intervention 643 800	Human synthetic secretin, mean dose 3.4 clinical units, and placebo were administered intravenously in randomized order every 4th wk, on three occasions each
T2	Intervention 802 910	The measurement instruments were the visual analogue scale (VAS) and the aberrant behaviour checklist (ABC).
